Go to Header
Go to Navigation
Go to Content
Go to Footer
Login
Help
中文（繁體）
Research Resources
CUHK UPDates
Theses
Experts List
User Guides
About Us
List of Researchers
> Master; Pro-Vice-Chancellor; Professor of Clinical Oncology (Clinical) Tak Cheung Anthony CHAN
Home
Research Outputs
Researcher Profiles
Department Profiles
Research Areas
Professor CHAN Anthony T.C.
Personal Information
Position and Department
Pro-Vice-Chancellor
,
Pro-Vice-Chancellor's Office - Prof. Anthony T.C. Chan
Master
,
Wu Yee Sun College
Professor of Clinical Oncology (Clinical)
,
Department of Clinical Oncology
ORCiD
0000-0002-6912-8091
CUHK Research Outputs
1 of 15
Abstract 3170: Epigenetic identification and functional characterization of a novel RING finger protein tumor suppressor in nasopharyngeal carcinoma and esophageal carcinoma
(
2024
)
Clinical Experience of Intrafractional Motion Monitoring of Patients Under Head and Neck Radiation Therapy Using ExacTrac Dynamic System
(
2024
)
Early detection of nasopharyngeal carcinoma: performance of a short contrast-free screening magnetic resonance imaging
(
2024
)
Nasopharyngeal cancer screening with an anti-BNLF2b antibody: a new arrow in the quiver?
(
2024
)
A novel tumor suppressor encoded by a 1p36.3 lncRNA functions as a phosphoinositide-binding protein repressing AKT phosphorylation/activation and promoting autophagy
(
2023
)
Artificial intelligence-powered spatial analysis of tumor microenvironment (TME) in nasopharyngeal carcinoma (NPC) patients treated with immune checkpoint inhibitors (ICI)
(
2023
)
Association of plasma Epstein-Barr virus DNA and clinical response in patients with recurrent and/or metastatic nasopharyngeal cancer treated with pembrolizumab or standard-of-care chemotherapy in KEYNOTE-122
(
2023
)
Fragmentation landscape of cell-free DNA revealed by deconvolutional analysis of end motifs
(
2023
)
Frequency of Peripheral CD8+ T Cells Expressing Chemo-Attractant Receptors CCR1, 4 and 5 Increases in NPC Patients with EBV Clearance upon Radiotherapy
(
2023
)
Immunotherapy for Head and Neck Cancer
(
2023
)
Immunotherapy for Nasopharyngeal Carcinoma: The Earlier the Better
(
2023
)
Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial
(
2023
)
NEOSPACE trial: Neoadjuvant pembrolizumab-gemcitabine-cisplatin followed by concurrent pembrolizumab-chemoradiation and maintenance pembrolizumab for stage IVA nasopharyngeal cancer (NPC)
(
2023
)
Plasma Epstein–Barr Virus DNA and Risk of Future Nasopharyngeal Cancer
(
2023
)
Preclinical evaluation of the VEGF/Ang2 bispecific nanobody BI 836880 in nasopharyngeal carcinoma models
(
2023
)
Recommendations for Epstein-Barr virus-based screening for nasopharyngeal cancer in high- and intermediate-risk regions
(
2023
)
Role of chemotherapy in patients with nasopharynx carcinoma treated with radiotherapy (MAC-NPC): an updated individual patient data network meta-analysis
(
2023
)
CpG methylation as epigenetic biomarkers for nasopharyngeal carcinoma diagnostics
(
2022
)
ESMO-EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease
(
2022
)
Exploratory Study of NPC-0501 Trial: Optimal Cisplatin Dose of Concurrent and Induction/Adjuvant Chemotherapy for Locoregionally Advanced Nasopharyngeal Carcinoma
(
2022
)
Identifying optimal clinical trial candidates for locoregionally advanced nasopharyngeal carcinoma: Analysis of 9468 real-world cases and validation by two phase 3 multicentre, randomised controlled trial
(
2022
)
Immunotherapy in Recurrent and Metastatic Nasopharyngeal Carcinoma
(
2022
)
Improved risk stratification of nasopharyngeal cancer by targeted sequencing of Epstein–Barr virus DNA in post-treatment plasma
(
2022
)
Magnetic-field-modulated radiotherapy (MagMRT) in inhomogeneous medium and its potential applications
(
2022
)
Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients
(
2022
)
Opportunities and challenges in combining immunotherapy and radiotherapy in head and neck cancers
(
2022
)
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial
(
2022
)
Prospective Randomized Phase II Study of Stereotactic Body Radiotherapy (SBRT) vs. Conventional Fractionated Radiotherapy (CFRT) for Chinese Patients with Early-Stage Localized Prostate Cancer
(
2022
)
Shift detection discrepancy between ExacTrac Dynamic system and cone-beam computed tomography
(
2022
)
The effect of material assignment in nasal cavity on dose calculation for nasopharyngeal carcinoma (NPC) using Acuros XB
(
2022
)
The radiobiological effect of using Acuros XB vs anisotropic analytical algorithm on hepatocellular carcinoma stereotactic body radiation therapy
(
2022
)
Analysis of Hepatocellular Carcinoma Stereotactic Body Radiation Therapy Dose Prescription Method Using Uncomplicated Tumor Control Probability Model
(
2021
)
Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline
(
2021
)
Commissioned Programme on the CUHK Phase 1 Clinical Trial Centre at the Prince of Wales Hospital
(
2021
)
Durability of the parotid-sparing effect of intensity-modulated radiotherapy (IMRT) in early stage nasopharyngeal carcinoma: A 15-year follow-up of a randomized prospective study of IMRT versus two-dimensional radiotherapy
(
2021
)
Dynamic Changes of Post-Radiotherapy Plasma Epstein-Barr Virus DNA in a Randomized Trial of Adjuvant Chemotherapy Versus Observation in Nasopharyngeal Cancer
(
2021
)
Health-related quality of life (HRQoL) with pembrolizumab (pembro) vs chemotherapy (chemo) in platinum-pretreated recurrent or metastatic (R/M) nasopharyngeal cancer (NPC): Phase III KEYNOTE-122 study
(
2021
)
Nasopharyngeal Carcinoma: An Evolving Paradigm
(
2021
)
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up
(
2021
)
NPC patients with post-RT EBV clearance show a higher frequency of peripheral CD8 T-cells expressing chemo-attractant receptors at baseline and during radiation therapy
(
2021
)
Preclinical evaluation of VEGF Ang2 bispecific nanobody BI836880 in patient-derived xenograft models of nasopharyngeal carcinoma
(
2021
)
Results of KEYNOTE-122: a phase 3 study of pembrolizumab (pembro) monotherapy vs chemotherapy (chemo) for platinum-pretreated, recurrent or metastatic (R/M) nasopharyngeal carcinoma (NPC)
(
2021
)
The effect of the magnetic fields from three different configurations of the MRIgRT systems on the dose deposition from lateral opposing photon beams in a laryngeal geometry – A Monte Carlo study
(
2021
)
The effect on tumour control probability of using AXB algorithm in replacement of AAA for SBRT of hepatocellular carcinoma located at lung-liver boundary region
(
2021
)
The expanding universe of checkpoint inhibitors for nasopharyngeal cancer
(
2021
)
Towards magnetic-field-modulated radiotherapy (MagMRT) with an MR-LINAC—a Monte Carlo study
(
2021
)
Whole-genome profiling of nasopharyngeal carcinoma reveals viral-host co-operation in inflammatory NF-κB activation and immune escape
(
2021
)
Early Detection of Cancer: Evaluation of MR Imaging Grading Systems in Patients with Suspected Nasopharyngeal Carcinoma
(
2020
)
Germline Polymorphisms and Length of Survival of Nasopharyngeal Carcinoma: An Exome-Wide Association Study in Multiple Cohorts
(
2020
)
Integrating postradiotherapy plasma Epstein–Barr virus DNA and TNM stage for risk stratification of nasopharyngeal carcinoma to adjuvant therapy
(
2020
)
Most Relevant Area
Oncology
(
Internal medicine related
)
Share Link
Last updated on 2024-03-09 at 16:08
Share Link
Your name*
Your email*
Recipient's name*
Recipient's email*
Message
Auxilliary Information
No information will be stored or shared with any third party.
Cancel
Our policy towards the use of cookies
All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Ok to Continue
Cookie Policy
